corra cervical plating system
Carlsmed, Inc. · Decision date Sep 24, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent decision dated September 24, 2026 for the corra® cervical plating system submitted by Carlsmed, Inc. under K262149. The device is a Class II spinal intervertebral body fixation orthosis under 21 CFR 888.3060, product code KWQ, intended for anterior cervical fixation from C2 to T1 and for use with the aprevo® cervical interbody system. The submission was dated August 21, 2026 and received August 24, 2026.
The clearance rests on comparison with the primary predicate K260570, also a corra® cervical plating system from the same applicant, covering intended use, technological characteristics and non-clinical testing, including mechanical testing per ASTM F1717 and cadaveric evaluation. The summary states clinical testing was not applicable and that the equivalence determination was not based on clinical performance data. The record does not identify which design, material or labeling elements changed relative to the predicate, and no indications beyond those listed are documented here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 24, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262149
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Carlsmed, Inc.
- Product code
- KWQ
- Decision code
- SESE
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Appliance, Fixation, Spinal Intervertebral Body.
- Applicant
- Carlsmed, Inc.
- Product code
- KWQ
- FDA device class
- 2
FDA decision timeline
K262149 received
Application receipt date recorded by FDA.
K262149 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Carlsmed, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Carlsbad, CA
Sources and methodology
- Original FDA record: K262149
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records